ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 258 filers reported holding ACCELERON PHARMA INC in Q4 2020. The put-call ratio across all filers is 0.78 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $882,000 | +7.4% | 7,033 | +16.1% | 0.00% | 0.0% |
| Q1 2021 | $821,000 | +0.7% | 6,058 | -5.0% | 0.00% | 0.0% |
| Q4 2020 | $815,000 | -13.6% | 6,375 | -24.0% | 0.00% | -25.0% |
| Q3 2020 | $943,000 | +28.1% | 8,386 | +8.5% | 0.00% | +33.3% |
| Q2 2020 | $736,000 | +15.4% | 7,727 | +8.8% | 0.00% | 0.0% |
| Q1 2020 | $638,000 | +762.2% | 7,100 | +407.1% | 0.00% | – |
| Q4 2019 | $74,000 | -76.4% | 1,400 | -83.9% | 0.00% | -100.0% |
| Q3 2016 | $314,000 | -44.9% | 8,700 | -48.2% | 0.00% | -66.7% |
| Q2 2016 | $570,000 | +83.3% | 16,800 | +34.4% | 0.00% | +200.0% |
| Q3 2015 | $311,000 | -21.3% | 12,500 | 0.0% | 0.00% | -50.0% |
| Q2 2015 | $395,000 | -16.8% | 12,500 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $475,000 | -2.5% | 12,500 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $487,000 | +5.9% | 12,500 | -17.8% | 0.00% | +100.0% |
| Q3 2014 | $460,000 | +736.4% | 15,200 | +850.0% | 0.00% | – |
| Q1 2014 | $55,000 | -46.6% | 1,600 | -38.5% | 0.00% | – |
| Q4 2013 | $103,000 | – | 2,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 938,490 | $120,070,000 | 33.50% |
| Foresite Capital Management III, LLC | 108,630 | $13,898,000 | 16.15% |
| Octagon Capital Advisors LP | 112,363 | $14,376,000 | 4.98% |
| Artal Group S.A. | 1,400,000 | $179,116,000 | 3.84% |
| Avoro Capital Advisors LLC | 1,550,000 | $198,307,000 | 3.42% |
| Affinity Asset Advisors, LLC | 45,000 | $5,757,000 | 3.05% |
| NWI MANAGEMENT LP | 200,000 | $25,588,000 | 2.54% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 71,000 | $9,063,000 | 2.48% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,600,000 | $332,644,000 | 2.00% |
| Parkman Healthcare Partners LLC | 52,458 | $6,711,000 | 1.72% |